US OptionsDetailed Quotes
DRIO250516C5000
- 0.00
- 0.000.00%
15min DelayClose May 9 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV567.56%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.50Leverage Ratio--Theta--Rho--Eff Leverage--Vega
DarioHealth Stock Discussion
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
Leading US Medical Center Chooses DarioHealth's AI Platform for Multi-Condition Care
4 MINUTES AGO, 8:30 AM EDT
VIA PR NEWSWIRE
Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition management
NEW YORK, April 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company...
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth
Monday, 24th March at 10:59 am
Hinge Health's s-1 filing seems to shed a light on DarioHealth's potential opportunity; With Hinge targeting a potential $3-6B IPO valuation with similar growth metrics, Dario's comparable 32.9% revenue growth, superior 80%+ gross margins, and multi-condition platform addressing the $1.2 trillion cardiometabolic disease mar...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
FY 2024 GAAP EPS $0.61 Beats $(1.01) Estimate, Sales $27.040M Beat $26.821M Estimate
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue
Monday, 10th March at 9:43 am
Digital health leader DarioHealth outperforms forecast with multi-condition platform, 90%+ client retention, 5x ROI for payers, expands Medicare/Medicaid partnerships, accelerates path to profitability with 83 client base, GLP-1 integrations, and surging heal...
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement With Rula
PR Newswire· 2 mins ago
The strategic arrangement fuels Dario's B2B2C sales growth, expanding access to over 15,000 providers nationwide
NEW YORK, March 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic collaboration with Rula Health, a leading provide...
No comment yet